PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	16.38	50.18	68.04	85.4	2.2	0.89
Cash & Short-Term Investments	16.76	50.18	68.04	85.4	2.2	0.89
Cash Growth	-72.63%	-26.25%	-20.33%	3778.14%	146.08%	73.67%
Prepaid Expenses	0.21	0.26	0.11	0.09	0.07	0.14
Total Current Assets	16.96	50.44	68.15	85.49	2.28	1.04
Long-Term Investments	18.63	-	1.57	1.57	1.57	1.57
Other Intangible Assets	1.55	1.55	3.55	3.55	3.55	3.55
Other Long-Term Assets	6.69	7.91	0.01	0.01	0.01	0.01
Total Assets	43.83	59.9	73.28	90.62	7.4	6.17
Accounts Payable	0.48	0.39	0.13	0.21	0.17	0.19
Accrued Expenses	0.71	0.74	0.46	0.5	0.5	0.7
Short-Term Debt	-	-	-	-	0.05	0.11
Current Portion of Long-Term Debt	-	-	-	-	-	0.03
Other Current Liabilities	-	0.46	-	-	-	-
Total Current Liabilities	1.19	1.59	0.59	0.7	0.72	1.03
Long-Term Debt	-	-	-	-	-	0.05
Other Long-Term Liabilities	2.38	12.97	-	-	-	-
Total Liabilities	3.58	14.56	0.59	0.7	0.72	1.08
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	181.43	185.33	202.23	201.58	114.11	108.97
Retained Earnings	-96.72	-115.63	-115.96	-111.65	-107.41	-103.86
Treasury Stock	-44.43	-42.04	-13.56	-	-	-
Comprehensive Income & Other	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Total Common Equity	40.25	27.65	72.69	89.92	6.68	5.09
Shareholders' Equity	40.25	45.35	72.69	89.92	6.68	5.09
Total Liabilities & Equity	43.83	59.9	73.28	90.62	7.4	6.17
Total Debt	-	-	-	-	0.05	0.19
Net Cash (Debt)	16.76	50.18	68.04	85.4	2.15	0.71
Net Cash Growth	-72.63%	-26.25%	-20.33%	3869.72%	204.54%	37.10%
Net Cash Per Share	2.18	5.24	3.49	5.50	1.49	0.78
Filing Date Shares Outstanding	6.86	7.71	8.78	20.75	1.61	1.56
Total Common Shares Outstanding	6.9	8.04	16.79	20.72	1.59	1.09
Working Capital	15.77	48.85	67.56	84.79	1.55	0.01
Book Value Per Share	5.83	3.44	4.33	4.34	4.20	4.66
Tangible Book Value	38.7	26.1	69.14	86.37	3.13	1.54
Tangible Book Value Per Share	5.60	3.25	4.12	4.17	1.97	1.41

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q